Intrinsiqq
Health In Tech Inc. logo

Health In Tech Inc.

HIT

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$37M
EPS-$0.07
P/E-8.49
P/FCF–
EV/EBITDA12.59
FCF Yield–
Div. Yield–
Net Debt/FCF–
Health In Tech Inc. intrinsic value
52-Week Range
$0.54$1.77

Profitability & Returns

Revenue (TTM)

$33M

▲ +71.0% YoY

Net Income (TTM)

-$4M

▲ +90.7% YoY

Op. Margin

3.36%

▼ -4.1pp YoY

ROIC

4.58%

▼ -2.0pp YoY

Cash Flow & Balance Sheet

FCF

N/A

Op. Cash Flow (TTM)

-$5M

▲ +44.0% YoY

Net Debt

-$6M

Net Cash Position

Cash & Equiv.

$7M

Continue Research

Peers

Insurance Agents, Brokers & Service · Pick stocks to compare with HIT

CompareIntrinsic value
QDMIQDM International Inc.
$16.46+51.01%65
RDZNRoadzen Inc.
$1.15-1.71%30
EZRAReliance Global Group, Inc.
$2.00-23.37%25
AIFUAIFU Inc.
$8.14+2.91%10
GOCOGoHealth Inc.
$0.06+22.22%0
NPNeptune Insurance Holdings Inc.
$28.22+0.18%29
HUIZHuize Holding Ltd
$2.27+0.67%44
TWFGTWFG, Inc.
$27.09+1.12%93

Health In Tech (HIT) in four numbers

Fair value (revenue)
$1.86
Price $0.59 is 68% below it.
Intrinsic Value
Quality score
25/100
Best check: revenue growth, 19.7%. Weakest: return on capital, 4.6%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-8.49
Negative: a loss over the last twelve months.
Financials

Questions about Health In Tech

Is Health In Tech (HIT) overvalued?

At $0.59, Health In Tech's price is 68% below the $1.86 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Health In Tech's fair value?

Intrinsiqq's calculator puts Health In Tech's fair value at $1.86 a share. It grows revenue per share 20% a year for 5 years, applies an exit P/S of 2.3, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $1.39. Every input can be changed on the Intrinsic Value tab.

Is Health In Tech a high-quality business?

Health In Tech scores 25 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 5 checks computed from SEC filings. Its best check is revenue growth at 19.7%, and its weakest is return on capital at 4.6%. The Quality tab shows every check against its target.

Does Health In Tech (HIT) pay a dividend?

No. Health In Tech (HIT) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 13 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 10 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in HIT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing HIT

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.